跳至主要内容
临床试验/IRCT20180309039013N1
IRCT20180309039013N1招募中3 期

Comparative clinical study of the effectiveness of TauroLock™ solution with piperacillin-tazobactam as secondary prophylaxis of Port-Catheter infection in children with cancer

Shiraz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
50